
Zhong Huijuan
$19.66B
as of 11/11/25
About Zhong Huijuan
Zhong Huijuan is the chairman and CEO of Chinese drugmaker Hansoh Pharmaceutical Group, which produces oncology, psychoactive, antidiabetic and other drugs.
Zhong's husband, Sun Piaoyang, is also a billionaire and leads Jiangsu Hengrui Pharmaceuticals, which is dual-listed in Shanghai and Hong Kong.
Their daughter, Sun Yuan, is Hansoh's executive director.
Headquartered in the Chinese coastal city of Lianyungang, Hansoh went public on the Hong Kong Stock Exchange in 2019.
Hansoh has licensed products including weight-loss treatments to global pharmaceutical giants such as Merck in billion-dollar deals, as the firm expands internationally.
Personal stats
Citizenship
People's Republic of ChinaSource of wealth
PharmaceuticalsResidence
Shanghai, ShanghaiMarital status
MarriedBirth date
01/01/61 (age 64)Number of children
1Education
Bachelor of Science, Jiangsu Normal University; EMBA, Nanjing UniversitySelf-made
self-madeZhong Huijuan’s fortune is worth

328K
troy ounces of gold

303K
median U.S. household

197K
median U.S. income

0.393%
U.S. credit card volume

0.079%
GDP of the United States

0.058%
United States debt
Net worth history
Annual ranking
Net worth over time
Real-time ranking
Financial assets
HONG KONG | 3692-HK
Hansoh Pharmaceutical GroupSHANGHAI | 600276-CN
Jiangsu Hengrui MedicineImages © Forbes.com. All rights reserved.
